Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeHOSPITALSJupiter Medical Center Establishes Command Center to Bolster COVID-19 Preparedness

Jupiter Medical Center Establishes Command Center to Bolster COVID-19 Preparedness

Since January, Jupiter Medical Center’s medical staff leadership, infection prevention experts and executive team have been developing plans to screen, isolate and treat COVID-19 patients, including conducting drills and training for hospital team members and ensuring the careful stewardship of equipment and supplies. The medical center was one of the first hospitals to implement CDC guidelines for the screening, diagnosis, and treatment of COVID-19 and since has also been working closely with the Florida Department of Health to strictly adhere to state and federal guidelines.

To streamline and centralize hospital operations in order to address an expected increase in patient volume of COVID-19 patients, Jupiter Medical Center has established an Incident Command Center. Similar to the actions the regional medical center would take during a hurricane, the command center offers a dedicated structure to streamline communication and provide administrative oversight to manage patient treatment, clinical staffing, and the allocation of rooms, equipment and supplies.

“Consistent with leading national and regional hospitals across the country, we implemented a series of comprehensive measures early to improve our readiness,” said Dr. Amit Rastogi, president and chief executive officer. “In addition to strictly adhering to CDC guidelines, we initiated additional preventive measures and began multidisciplinary training to prepare our team members to recognize and screen potential cases, implement isolation protocols, and properly use personal protective equipment (PPE) while treating patients,” Dr. Rastogi continued.

The regional medical center also confirmed that it is starting to see patients who have tested positive for COVID-19. As required by federal privacy laws, Jupiter Medical Center is prevented from releasing any personal details about patients undergoing treatment.

Most recently, the medical center adopted The American College of Surgeons’ recommendations and began rescheduling non-urgent, elective surgeries to increase capacity and minimize the potential of COVID-19 exposure among patients, team members, and frontline providers.

“We will continue to perform nonelective, urgent and emergency surgeries,” Dr. Rastogi said. “However, by reducing the number of elective procedures, we are able to conserve our supply of personal protective equipment, beds, and ventilators for use in patients with critical illnesses, and ensure that more of our clinical team members are available to care for patients who are most in need when the time comes.”

Jupiter Medical Center is not a designated COVID-19 testing site, in accordance with directives from the Florida Department of Health. Public health authorities have advised that hospitals should not be used for non-critical conditions or non-emergencies, including coronavirus testing. Individuals experiencing symptoms – fever, cough or difficulty breathing – are urged to call their physician or contact one of several state-designated testing sites that are equipped to take swabs for testing and send them to the appropriate lab.

The medical center continues to engage national and regional suppliers to procure additional resources and supplies, such as test kits, N95 respirator masks, and ventilators, to identify and treat those who may require hospitalization. In addition to implementing the necessary personal protective equipment (PPE) to protect frontline caregivers, Jupiter Medical Center is leveraging the use of Tru-D SmartUVC ultra-violet disinfection robots that deconstruct the DNA of deadly pathogens and eliminate common health care-associated infection culprits.

Jupiter Medical Center has implemented a ‘no visitation’ policy with the exception of Labor & Delivery and Pediatric patients, who will be permitted one visitor. While the hospital recognizes this policy is highly inconvenient for patients and their loved ones, it is becoming necessary to reduce the likelihood of exposure.

The medical center has temporarily suspended health and wellness classes, professional CME and community events. Volunteer services and the hospital’s Motor Aid patient transport system also have been suspended.

If you or a loved one are exhibiting symptoms of COVID-19, members of the public are advised to call their primary care provider (PCP) for a screening. Or you may call the Florida Department of Health’s COVID-19 hotline which is available 24 hours a day and 7 days a week at 1 (866) 779-6121.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy